LON:IDP

InnovaDerma (IDP) Share Price, News & Analysis

InnovaDerma logo

About InnovaDerma Stock (LON:IDP)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
5,000 shs
Average Volume
106,039 shs
Market Capitalization
£8.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovaDerma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDP Stock News Headlines

Innovaderma Stock Price History
IDP Education: IDP to acquire Intake Education
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst environment in 50 years - with portfolios potentially staying in the red for 10 years or longer. From rate spikes in 2022 to $12 trillion wiped out in 30 days during the Iran War, Wall Street suggests the volatility isn't slowing down. TradeSmith CEO Keith Kaplan is showing investors what steps to take now to prepare their wealth before this worsens.tc pixel
See More Headlines

IDP Stock Analysis - Frequently Asked Questions

InnovaDerma PLC (LON:IDP) issued its earnings results on Wednesday, September, 30th. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of $9.50 by $11.50.

Shares of IDP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovaDerma investors own include Sol-Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), Avino Silver & Gold Mines (ASM), BJ's Restaurants (BJRI), eHealth (EHTH).

Company Calendar

Last Earnings
9/30/2020
Today
6/20/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Specialty Retail
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:IDP
CIK
N/A
Fax
N/A
Employees
8,720
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
55.52
Current Ratio
1.93
Quick Ratio
1.04

Sales & Book Value

Annual Sales
£9.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.92
Book Value
GBX 7.90 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,058,000
Free Float
N/A
Market Cap
£8.14 million
Optionable
Not Optionable
Beta
N/A
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (LON:IDP) was last updated on 6/20/2026 by MarketBeat.com Staff.
From Our Partners